IL6 and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma (ESCC), IL-6 released by CAFs increased the chemoresistance of ESCC to cisplatin by increasing the chemokine receptor CXCR7 expression in tumor cells through the STAT3/NF-κB axis (117).